Published in J Neurooncol on July 05, 2012
Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways. Neuro Oncol (2013) 0.93
Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas. Front Oncol (2013) 0.86
Necrosis, and then stress induced necrosis-like cell death, but not apoptosis, should be the preferred cell death mode for chemotherapy: clearance of a few misconceptions. Oncoscience (2014) 0.84
Preclinical pharmacological evaluation of a novel multiple kinase inhibitor, ON123300, in brain tumor models. Mol Cancer Ther (2014) 0.80
Hyperbaric oxygen promotes malignant glioma cell growth and inhibits cell apoptosis. Oncol Lett (2015) 0.76
MicroRNA-210 and Endoplasmic Reticulum Chaperones in the Regulation of Chemoresistance in Glioblastoma. J Cancer (2015) 0.75
Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers. Oncogenesis (2017) 0.75
HIF1α regulates glioma chemosensitivity through the transformation between differentiation and dedifferentiation in various oxygen levels. Sci Rep (2017) 0.75
Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas. PLoS One (2017) 0.75
MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med (2005) 29.65
Targeting HIF-1 for cancer therapy. Nat Rev Cancer (2003) 28.01
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol (2009) 25.96
The MAPK signaling cascade. FASEB J (1995) 10.81
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res (1999) 6.10
Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres. Am J Pathol (2010) 1.86
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma. J Clin Oncol (2009) 1.53
Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res (2005) 1.49
Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells (2010) 1.40
Hypoxia helps glioma to fight therapy. Curr Cancer Drug Targets (2009) 1.32
Acquisition of temozolomide chemoresistance in gliomas leads to remodeling of mitochondrial electron transport chain. J Biol Chem (2010) 1.30
Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis. J Immunol (2003) 1.27
Glioma therapy in adults. Neurologist (2006) 1.26
Multifaceted resistance of gliomas to temozolomide. Clin Cancer Res (2002) 1.22
AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme. Adv Ther (2011) 1.20
A review of oxygen therapy in ischemic stroke. Neurol Res (2007) 1.20
Malignant glioma physiology: cellular response to hypoxia and its role in tumor progression. Ann Intern Med (2003) 1.17
Hyperoxia-induced signal transduction pathways in pulmonary epithelial cells. Free Radic Biol Med (2007) 1.16
Long-term in vitro treatment of human glioblastoma cells with temozolomide increases resistance in vivo through up-regulation of GLUT transporter and aldo-keto reductase enzyme AKR1C expression. Neoplasia (2010) 1.15
Bcl-2 family gene expression during severe hyperoxia induced lung injury. Lab Invest (2000) 1.14
Mitogen-activated protein kinase pathway mediates hyperoxia-induced apoptosis in cultured macrophage cells. Am J Physiol (1999) 1.09
Hyperoxia retards growth and induces apoptosis, changes in vascular density and gene expression in transplanted gliomas in nude rats. J Neurooncol (2007) 1.09
Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model. PLoS One (2009) 1.09
Genetic alterations associated with acquired temozolomide resistance in SNB-19, a human glioma cell line. Mol Cancer Ther (2006) 1.06
MAPK pathways mediate hyperoxia-induced oncotic cell death in lung epithelial cells. Free Radic Biol Med (2003) 1.05
Overcoming therapeutic resistance in malignant gliomas: current practices and future directions. Cancer Treat Res (2008) 1.04
ERK activation protects against DNA damage and apoptosis in hyperoxic rat AEC2. Am J Physiol (1999) 1.02
Change of oxygen pressure in glioblastoma tissue under various conditions. J Neurooncol (2002) 1.02
Hypoxia-inducible factor-1 inhibition in combination with temozolomide treatment exhibits robust antitumor efficacy in vivo. Clin Cancer Res (2006) 1.01
Hyperbaric oxygen alone or combined with 5-FU attenuates growth of DMBA-induced rat mammary tumors. Cancer Lett (2004) 0.96
Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines. J Neurooncol (2011) 0.94
1, 9-Pyrazoloanthrones downregulate HIF-1α and sensitize cancer cells to cetuximab-mediated anti-EGFR therapy. PLoS One (2010) 0.92
Normobaric hyperoxia therapy for traumatic brain injury and stroke: a review. Br J Neurosurg (2009) 0.89
Hyperbaric oxygen inhibits benign and malignant human mammary epithelial cell proliferation. Anticancer Res (2005) 0.89
The effect of hyperbaric oxygen on growth and chemosensitivity of metastatic prostate cancer. Anticancer Res (1998) 0.89
Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of metastatic lung tumors in a rat model. J Thorac Cardiovasc Surg (2003) 0.88
Chemo-resistant protein expression pattern of glioblastoma cells (A172) to perillyl alcohol. J Proteome Res (2010) 0.88
Acute hyperoxia increases lipid peroxidation and induces plasma membrane blebbing in human U87 glioblastoma cells. Neuroscience (2009) 0.88
Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole. BMC Cancer (2010) 0.88
Hyperoxia increases the uptake of 5-fluorouracil in mammary tumors independently of changes in interstitial fluid pressure and tumor stroma. BMC Cancer (2009) 0.86
Hyperbaric oxygen as a chemotherapy adjuvant in the treatment of osteosarcoma. Oncol Rep (2009) 0.83
Use of 5-FU plus hyperbaric oxygen for treating malignant tumors: evaluation of antitumor effect and measurement of 5-FU in individual organs. Cancer Chemother Pharmacol (2001) 0.82
Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice. Cancer (1995) 0.82
Effect of long-term normobaric hyperoxia on oxidative stress in mitochondria of the guinea pig brain. Neurochem Res (2011) 0.81
A phase II study of radiotherapy after hyperbaric oxygenation combined with interferon-beta and nimustine hydrochloride to treat supratentorial malignant gliomas. J Neurooncol (2003) 0.81
Hyperoxia-induced activation of the integrated stress response in the newborn rat lung. Am J Physiol Lung Cell Mol Physiol (2011) 0.80
Hyperoxia and traumatic brain injury. J Neurosurg (2009) 0.80
[Pulmonary apoptosis and necrosis in hyperoxia-induced acute mouse lung injury]. Zhonghua Jie He He Hu Xi Za Zhi (2004) 0.77
A combination of radiotherapy, nitric oxide and a hyperoxygenation sensitizing protocol for brain malignant tumor treatment. Med Hypotheses (2006) 0.77
[Usefulness of hyperbaric oxygen in the treatment of radionecrosis and symptomatic brain edema after LINAC radiosurgery]. Neurocirugia (Astur) (2009) 0.77
Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet (2012) 4.07
Genomic portrait of resectable hepatocellular carcinomas: implications of RB1 and FGF19 aberrations for patient stratification. Hepatology (2014) 3.31
Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res (2013) 2.12
In vivo cardiac reprogramming contributes to zebrafish heart regeneration. Nature (2013) 1.79
Long non-coding RNA expression profiles predict clinical phenotypes in glioma. Neurobiol Dis (2012) 1.70
Pipeline embolization device for intracranial aneurysm: a systematic review. Clin Neuroradiol (2012) 1.53
Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study. BMJ Open (2012) 1.50
Safety and comfort during sedation for diagnostic or therapeutic procedures. Hong Kong Med J (2002) 1.48
Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells. J Biol Chem (2012) 1.43
Preliminary results of radiation dose escalation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys (2005) 1.41
DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival. J Biol Chem (2011) 1.40
An epithelial cyst in the cerebellopontine angle. Case report. J Neurosurg (1991) 1.39
Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence. Mol Cell Proteomics (2007) 1.39
Endoscopic cranionasal resection of anterior skull base tumor. Am J Otolaryngol (1998) 1.37
Targeting cadherin-17 inactivates Wnt signaling and inhibits tumor growth in liver carcinoma. Hepatology (2009) 1.32
Dysembryoplastic neuroepithelial tumor. A tumor with small neuronal cells resembling oligodendroglioma. Am J Surg Pathol (1994) 1.23
Maxillary swing approach for resection of tumors in and around the nasopharynx. Arch Otolaryngol Head Neck Surg (1995) 1.12
Osteopontin as potential biomarker and therapeutic target in gastric and liver cancers. World J Gastroenterol (2012) 1.10
Primary histiocytic lymphoma of the central nervous system: a neoplasm frequently overshadowed by a prominent inflammatory component. Am J Surg Pathol (2001) 1.07
Occult hepatitis B virus infection in hematopoietic stem cell donors in a hepatitis B virus endemic area. J Hepatol (2005) 1.06
Chiari III malformation: antenatal MRI diagnosis. Clin Radiol (2002) 1.04
Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin. Int J Cancer (2011) 1.03
HIVID: an efficient method to detect HBV integration using low coverage sequencing. Genomics (2013) 1.02
Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. J Hepatol (2007) 1.00
Ganglioneuroma of the spinal cord. Surg Neurol (1991) 0.94
Dickkopfs and Wnt/β-catenin signalling in liver cancer. World J Clin Oncol (2011) 0.94
Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage. World J Surg (2012) 0.94
Protein alterations associated with temozolomide resistance in subclones of human glioblastoma cell lines. J Neurooncol (2011) 0.94
Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways. Neuro Oncol (2013) 0.93
Proteomics of hepatocellular carcinoma: serum vimentin as a surrogate marker for small tumors (<or=2 cm). J Proteome Res (2010) 0.93
Maggot debridement therapy in chronic wound care. Hong Kong Med J (2007) 0.92
Matrix metalloproteinase-9 is differentially expressed in nonfunctioning invasive and noninvasive pituitary adenomas and increases invasion in human pituitary adenoma cell line. Am J Pathol (2007) 0.90
Size, location, and multiplicity of ruptured intracranial aneurysms in the Hong Kong Chinese population with subarachnoid haemorrhage. Hong Kong Med J (2009) 0.90
The pathological spectrum of desmoplastic infantile gangliogliomas. Histopathology (1990) 0.89
Retrograde suction decompression of paraclinoid aneurysm--a revised technique. Surg Neurol (1999) 0.88
Heat shock proteins in cancer: signaling pathways, tumor markers and molecular targets in liver malignancy. Protein Pept Lett (2009) 0.87
Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model. Liver Int (2007) 0.86
Circulating markers for prognosis of hepatocellular carcinoma. Expert Opin Med Diagn (2013) 0.86
Effects of progesterone vs. dexamethasone on brain oedema and inflammatory responses following experimental brain resection. Brain Inj (2014) 0.86
Injury Severity Score (ISS) vs. ICD-derived Injury Severity Score (ICISS) in a patient population treated in a designated Hong Kong trauma centre. Mcgill J Med (2008) 0.85
Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2. Dig Dis Sci (2014) 0.85
Anti-cadherin-17 antibody modulates beta-catenin signaling and tumorigenicity of hepatocellular carcinoma. PLoS One (2013) 0.84
Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma. PLoS One (2011) 0.83
Prospective double-blind placebo-controlled randomized trial on the use of ranitidine in preventing postoperative gastroduodenal complications in high-risk neurosurgical patients. J Neurosurg (1995) 0.83
Functional survival after acute care for severe head injury at a designated trauma center in Hong Kong. Asian J Surg (2012) 0.83
Angioplasty and stenting for intracranial atherosclerotic stenosis: position statement of the Hong Kong Society of Interventional and Therapeutic Neuroradiology. Hong Kong Med J (2013) 0.83
Expression of ankyrin repeat and SOCS box containing 4 (ASB4) confers migration and invasion properties of hepatocellular carcinoma cells. Biosci Trends (2014) 0.82
MRI features of spinal ganglioglioma. Clin Imaging (1991) 0.81
Hepatic tight junctions: from viral entry to cancer metastasis. World J Gastroenterol (2010) 0.81
Analysis of shortened versions of the tampa scale for kinesiophobia and pain catastrophizing scale for patients after anterior cruciate ligament reconstruction. Clin J Pain (2012) 0.80
A multicenter multinational registry for assessing ventriculoperitoneal shunt infections for hydrocephalus. Neurosurgery (2010) 0.80
Unusual case of Klüver-Bucy syndrome in a Chinese boy. Pediatr Neurol (1992) 0.80
Immunologic effectiveness of maraviroc- and raltegravir-containing regimens (R+M+) versus raltegravir-based regimens that do not include maraviroc (R+M-). J Int Assoc Physicians AIDS Care (Chic) (2012) 0.80
Aneurysmal bone cyst presenting as Horner's syndrome. Skeletal Radiol (1995) 0.80
Entanglements of marine mammals and seabirds in central California and the north-west coast of the United States 2001-2005. Mar Pollut Bull (2009) 0.80
Adjuvant therapy for the reduction of postoperative intra-abdominal adhesion formation. Asian J Surg (2009) 0.79
Implications of the Use of Eukaryotic Translation Initiation Factor 5A (eIF5A) for Prognosis and Treatment of Hepatocellular Carcinoma. Int J Hepatol (2012) 0.79
Surgical recanalisation of thrombosed M2 trunk after coil embolisation of a ruptured middle cerebral artery aneurysm. Hong Kong Med J (2009) 0.79
Mechanical thrombectomy in acute proximal middle cerebral artery thrombosis with the alligator retrieval device. Cerebrovasc Dis (2006) 0.79
Tumor necrosis factor-alpha-induced protein 1 and immunity to hepatitis B virus. World J Gastroenterol (2005) 0.78
Spinal meningioma arising from a lumbar nerve root. Case report. J Neurosurg (1989) 0.78
Case report: magnetic resonance imaging of primary lymphoma of the cauda equina. Br J Radiol (1996) 0.78
Clinicopathologic and gene expression parameters predict liver cancer prognosis. BMC Cancer (2011) 0.78
Paradoxical response of a pineal immature teratoma to combination chemotherapy. Med Pediatr Oncol (1995) 0.78
Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinoma. Expert Rev Mol Diagn (2014) 0.77
Prognostic significance of phosphorylated RON in esophageal squamous cell carcinoma. Med Oncol (2011) 0.77
Retracted: outcome and immune reconstitution of HBV-specific immunity in patients with reactivation of occult HBV infection after alemtuzumab-containing chemotherapy regimen. Hepatology (2008) 0.76
Clinical correlation of nuclear survivin in esophageal squamous cell carcinoma. Med Oncol (2012) 0.76
Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy. J Clin Microbiol (2006) 0.76
Biomarkers for early detection of liver cancer: focus on clinical evaluation. Protein Pept Lett (2009) 0.76
Central neurocytoma: its differentiation from intraventricular oligodendroglioma. Childs Nerv Syst (1992) 0.75
Suprasellar ectopic pituitary adenoma presenting as cranial diabetes insipidus. Postgrad Med J (1992) 0.75
Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. J Clin Invest (2017) 0.75
Pituitary enlargement in spontaneous intracranial hypotension--a diagnostic pitfall. Acta Neurochir (Wien) (2011) 0.75
Using bevacizumab in the fight against malignant glioma: first results in Asian patients. Hong Kong Med J (2011) 0.75
Streamlining your business for success. Nat Biotechnol (2011) 0.75
Case report: Acute haemorrhagic presentation of trigeminal neuroma. Br J Radiol (1996) 0.75
Basilar impression in a child with hypochondroplasia. Pediatr Neurol (1991) 0.75
Arytenoid subluxation: implications for the anaesthetist. Anaesth Intensive Care (1996) 0.75
Whole-organ histopathological study of recurrent nasopharyngeal carcinoma. Laryngoscope (2013) 0.75
Test and teach. Number Sixty-four. Diagnosis: Pleomorphic xanthoastrocytoma. Pathology (1990) 0.75
Clinical undergraduate examination--voluntary patients' perspective. Med Teach (2010) 0.75
Investigation of nimodipine pharmacokinetics in Chinese patients with acute subarachnoid haemorrhage. Eur J Clin Pharmacol (1993) 0.75
Clinical sparganosis in Hong Kong. J R Soc Health (1989) 0.75
The use of small peptides in the diagnosis and treatment of hepatocellular carcinoma. Protein Pept Lett (2009) 0.75